The experimental biotech startup Verve Therapeutics has paused the first phase of a buzzy human gene-editing trial due to strange side effects in a patient, according to a report from Bloomberg. While ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Carlene Knight's vision was so bad ...

That rogue scientist who created HIV-resistant designer babies is apparently gearing up for more human gene-editing research. In an interview with the Wall Street Journal, He Jiankui said he wants to ...

Despite awe-inspiring diversity, nearly every lifeform – from bacteria to blue whales – shares the same genetic code. How and when this code came about has been the subject of much scientific ...